Oncotarget is a medical journal published by Impact Journals. It carries in it peer-reviewed information on matters of cancer, an illness that is taking the lives of people left-right-and-center.
Cancer is a deadly illness, terminal to say the least. Any information giving a lead to better chances with cancer is much appreciable. Oncotarget is there for everyone, to ensure that people have access to cancer information every time they need it. Every week, Oncotarget provides readers with insightful and constructive information about cancer. The medical journal, edited by the knowledgeable Mikhail Blagosklonny and Andrei V. Gudkov, is like a revelation in the field of oncology. Mikhail is a known scientist for his dedication to issues of cancer. Information on cancer prevention, diagnosis and its treatment is available at Oncotarget week-in-week-out.
Download output styles at Endnote.com.
At stake for the followers and readers of Oncotarget is information on health. The weekly publication has made a step further and now publishes journals with information beyond oncology. They have been accepting peer-reviewed papers on cardiology, neuroscience, pharmacology, and other areas related to the expansive medical field.
Oncotarget is the home of winners. The authors and researchers have received accolades for their outstanding work in medical research. Their contribution has been magnificent, with Alexander Varshavsky, Michael N. Hall. Stephen J. Elledge, and Bert Volelstein winning the Breakthrough Prize since 2013 – a top award for medical researchers. With the information they provide, Oncotarget will help people remain cancer-free. It gives people the opportunity to learn for free about cancer-related issues.
To everyone, be part of the winners, remain informed about cancer, learn from the experts, and enjoy a cancer-free life. Only on Oncotarget.
Follow Oncotarget journal on Twitter.